Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
Doc Ophthalmol ; 119(3): 217-24, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19885692

ABSTRACT

To determine whether the Diagnosys full-field stimulus threshold (D-FST) is a valid, sensitive and repeatable psychophysical method of measuring and following visual function in low-vision subjects. Fifty-three affected eyes of 42 subjects with severe retinal degenerative diseases (RDDs) were tested with achromatic stimuli on the D-FST. Included were subjects who were either unable to perform a static perimetric field or had non-detectable or sub-microvolt electroretinograms (ERGs). A subset of 21 eyes of 17 subjects was tested on both the D-FST and the FST2, a previous established full-field threshold test. Seven eyes of 7 normal control subjects were tested on both the D-FST and the FST2. Results for the two methods were compared with the Bland-Altman test. On the D-FST, a threshold could successfully be determined for 13 of 14 eyes with light perception (LP) only (median 0.9 +/- 1.4 log cd/m2), and all eyes determined to be counting fingers (CF; median 0.3 +/- 1.8 log cd/m2). The median full-field threshold for the normal controls was -4.3 +/- 0.6 log cd/m2 on the D-FST and -4.8 +/- 0.9 log cd/m2 on the FST2. The D-FST offers a commercially available method with a robust psychophysical algorithm and is a useful tool for following visual function in low vision subjects.


Subject(s)
Retinal Degeneration/physiopathology , Sensory Thresholds , Vision, Low/physiopathology , Adolescent , Adult , Aged , Aged, 80 and over , Algorithms , Child , Child, Preschool , Electroretinography , Female , Humans , Male , Middle Aged , Photic Stimulation/methods , Psychophysics , Reproducibility of Results , Retinal Degeneration/complications , Sensitivity and Specificity , Vision, Low/etiology , Visual Field Tests
2.
Proc Natl Acad Sci U S A ; 102(11): 4164-9, 2005 Mar 15.
Article in English | MEDLINE | ID: mdl-15749821

ABSTRACT

Macular degeneration is a heterogeneous group of disorders characterized by photoreceptor degeneration and atrophy of the retinal pigment epithelium (RPE) in the central retina. An autosomal dominant form of Stargardt macular degeneration (STGD) is caused by mutations in ELOVL4, which is predicted to encode an enzyme involved in the elongation of long-chain fatty acids. We generated transgenic mice expressing a mutant form of human ELOVL4 that causes STGD. In these mice, we show that accumulation by the RPE of undigested phagosomes and lipofuscin, including the fluorophore, 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E,7E-octatetraenyl]-1-(2-hyydroxyethyl)-4-[4-methyl-6-(2,6,6,-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium (A2E) is followed by RPE atrophy. Subsequently, photoreceptor degeneration occurs in the central retina in a pattern closely resembling that of human STGD and age-related macular degeneration. The ELOVL4 transgenic mice thus provide a good model for both STGD and dry age-related macular degeneration, and represent a valuable tool for studies on therapeutic intervention in these forms of blindness.


Subject(s)
Eye Proteins/genetics , Lipofuscin/metabolism , Macular Degeneration/genetics , Membrane Proteins/genetics , Photoreceptor Cells/metabolism , Animals , Disease Models, Animal , Electrophysiology , Eye Proteins/metabolism , Humans , Macular Degeneration/metabolism , Membrane Proteins/metabolism , Mice , Mice, Transgenic , Microscopy, Electron , Photoreceptor Cells/ultrastructure , Retina/metabolism , Retina/pathology
3.
Br J Ophthalmol ; 87(10): 1268-71, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14507764

ABSTRACT

AIMS: To determine the interocular amplitude response difference of the electroretinogram (ERG) in normal subjects. METHODS: 79 subjects, without retinal changes of clinical significance, underwent ERG testing. They included 63 men and 16 women, with a mean age of 44 (SD 12) years and range of 18-65 years. Isolated rod, scotopic maximal, dark adapted 30 Hz flicker, photopic single flash, and light adapted 30 Hz flicker responses were recorded in both eyes following the International Society for Clinical Electrophysiology of Vision (ISCEV) standard protocol. The interocular percentage differences of the ERG b-wave amplitudes were calculated and presented as percentiles (25th, 50th, 75th, 95th), means (SD), and medians. RESULTS: The median interocular percentage differences in the b-wave amplitudes for the above ERG stimulus responses were 10%, 8%, 10%, 11%, and 10%, respectively. The mean interocular percentage differences were 11%, 11%, 12%, 13%, and 14%. The 95th percentiles for the interocular percentage differences were 28%, 27%, 36%, 33%, and 35%, respectively. CONCLUSIONS: The interocular percentage differences in the ERG b-wave amplitudes for five different stimulus responses were similar in our cohort of individuals without clinically significant retinal changes and ranged from a median of 8-11% and a 95th percentile of 27-36%. Our findings should be useful for determining sample sizes in future therapeutic trials on retinal diseases with monocular therapeutic strategies and may also have application for the more accurate detection of asymmetric retinal disease.


Subject(s)
Retina/physiology , Adaptation, Ocular/physiology , Adolescent , Adult , Aged , Dark Adaptation/physiology , Electroretinography , Female , Humans , Male , Middle Aged , Photic Stimulation , Prospective Studies , Retinal Rod Photoreceptor Cells/physiology
4.
Lipids ; 36(9): 885-95, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11724460

ABSTRACT

Essential fatty acids are structural components of all tissues and are indispensable for cell membrane synthesis; the brain, retina and other neural tissues are particularly rich in long-chain polyunsaturated fatty acids (LC-PUFA). These fatty acids serve as specific precursors for eicosanoids, which regulate numerous cell and organ functions. Recent human studies support the essential nature of n-3 fatty acids in addition to the well-established role of n-6 essential fatty acids in humans, particularly in early life. The main findings are that light sensitivity of retinal rod photoreceptors is significantly reduced in newborns with n-3 fatty acid deficiency, and that docosahexaenoic acid (DHA) significantly enhances visual acuity maturation and cognitive functions. DHA is a conditionally essential nutrient for adequate neurodevelopment in humans. Comprehensive clinical studies have shown that dietary supplementation with marine oil or single-cell oil sources of LC-PUFA results in increased blood levels of DHA and arachidonic acid, as well as an associated improvement in visual function in formula-fed infants matching that of human breast-fed infants. The effect is mediated not only by the known effects on membrane biophysical properties, neurotransmitter content, and the corresponding electrophysiological correlates but also by a modulating gene expression of the developing retina and brain. Intracellular fatty acids or their metabolites regulate transcriptional activation of gene expression during adipocyte differentiation and retinal and nervous system development. Regulation of gene expression by LC-PUFA occurs at the transcriptional level and may be mediated by nuclear transcription factors activated by fatty acids. These nuclear receptors are part of the family of steroid hormone receptors. DHA also has significant effects on photoreceptor membranes and neurotransmitters involved in the signal transduction process; rhodopsin activation, rod and cone development, neuronal dendritic connectivity, and functional maturation of the central nervous system.


Subject(s)
Brain/growth & development , Eye/growth & development , Fatty Acids, Essential/pharmacology , Fatty Acids, Essential/physiology , Brain/drug effects , Brain/physiology , Electrophysiology , Eye/drug effects , Female , Gene Expression Regulation , Humans , Infant, Newborn , Neurons/drug effects , Neurons/physiology
5.
J Lipid Res ; 42(9): 1395-401, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11518758

ABSTRACT

Many patients with X-linked retinitis pigmentosa (XLRP) have lower than normal blood levels of the long-chain polyunsaturated omega3 fatty acid docosahexaenoic acid (DHA; 22:6omega3). This clinical trial was designed to test whether down-regulation of DHA biosynthesis might be responsible for these reduced DHA levels. DHA biosynthesis was assessed in five severely affected patients with XLRP and in five age-matched controls by quantifying conversion of [U-(13)C]alpha-linolenic acid (alpha-LNA) to [(13)C]DHA. Following oral administration of [U-(13)C]alpha-LNA, blood samples were collected at designated intervals for 21 days and isotopic enrichment of all omega3 fatty acids was determined by gas chromatography/mass spectroscopy. Activity of each metabolic step in the conversion of alpha-LNA to DHA was determined by comparison of the ratios of the integrated concentration of (13)C-product to (13)C-precursor in plasma total lipid fractions. The ratio of [(13)C]DHA to [(13)C]18:3omega3 (the entire pathway) and that of [(13)C]20:5omega3 to [(13)C]20:4omega3 (Delta(5)-desaturase) were significantly lower in patients versus controls (P = 0.03 and 0.05, respectively). The estimated biosynthetic rates of [(13)C]20:5omega3, [(13)C]22:5omega3, [(13)C]24:5omega3, [(13)C]24:6omega3, and [(13)C]22:6omega3 were significantly lower in XLRP patients (42%, 43%, 31%, 18%, and 32% of control values, respectively; P < 0.04), supporting down-regulation of Delta(5)-desaturase in XLRP. The disappearance of (13)C-labeled fatty acids from plasma was not greater in XLRP patients compared with controls, suggesting that XLRP was not associated with increased rates of fatty acid oxidation or other routes of catabolism.Thus, despite individual variation among both patients and controls, the data are consistent with a lower rate of Delta(5)-desaturation, suggesting that decreased biosynthesis of DHA may contribute to lower blood levels of DHA in patients with XLRP.


Subject(s)
Docosahexaenoic Acids/blood , Genetic Linkage , Retinitis Pigmentosa/blood , X Chromosome , Adult , Breath Tests , Carbon Dioxide/analysis , Carbon Isotopes , Delta-5 Fatty Acid Desaturase , Fatty Acid Desaturases/metabolism , Fatty Acids, Omega-3/metabolism , Gas Chromatography-Mass Spectrometry , Humans , Kinetics , Male , Middle Aged , Oxidation-Reduction , Retinitis Pigmentosa/genetics , alpha-Linolenic Acid/metabolism
6.
Braz. j. med. biol. res ; 34(8): 1037-1040, Aug. 2001. ilus
Article in English | LILACS | ID: lil-290153

ABSTRACT

According to the equivalent light hypothesis, molecular defects in the photoreceptor lead to a continuous activation of the photoreceptor cascade in a manner equivalent to real light. The consequences in diseases such as retinitis pigmentosa (RP) are as disruptive to the cells as real light. Two forms of the equivalent light hypothesis can be distinguished: strong - mutations in rhodopsin or other cascade proteins in some forms of RP continuously excite the visual phototransduction cascade; weak - disruption of outer segments in all patients with RP eliminates circulating dark current and blocks neurotransmitter release in a manner similar to real light. Both forms of the equivalent light hypothesis predict that pupils of patients with RP will be constricted like those of normal subjects in the light. The purpose of this study was to test the equivalent light hypothesis by determining whether steady-state pupil diameter following full dark adaptation is abnormally small in any of a sample of patients with RP. Thirty-five patients with RP and 15 normal subjects were tested. Direct steady-state pupillometric measures were obtained from one eye in a full-field dome after 45 min of dark adaptation by videotaping the pupil with an infrared camera. Mean pupil diameter in the dark was comparable (t = -0.15, P = 0.88) between patients with RP (6.85 Ý 0.58 mm) and normal subjects (6.82 Ý 0.76 mm). The results of the present study are clearly counter to the prediction of the second (weaker) form of the equivalent light hypothesis


Subject(s)
Humans , Adult , Middle Aged , Dark Adaptation/physiology , Light , Pupil/physiology , Retinitis Pigmentosa/etiology , Case-Control Studies , Retina/anatomy & histology , Retina/physiology , Rod Cell Outer Segment/physiology
7.
Braz J Med Biol Res ; 34(8): 1037-40, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11471043

ABSTRACT

According to the equivalent light hypothesis, molecular defects in the photoreceptor lead to a continuous activation of the photoreceptor cascade in a manner equivalent to real light. The consequences in diseases such as retinitis pigmentosa (RP) are as disruptive to the cells as real light. Two forms of the equivalent light hypothesis can be distinguished: strong - mutations in rhodopsin or other cascade proteins in some forms of RP continuously excite the visual phototransduction cascade; weak - disruption of outer segments in all patients with RP eliminates circulating dark current and blocks neurotransmitter release in a manner similar to real light. Both forms of the equivalent light hypothesis predict that pupils of patients with RP will be constricted like those of normal subjects in the light. The purpose of this study was to test the equivalent light hypothesis by determining whether steady-state pupil diameter following full dark adaptation is abnormally small in any of a sample of patients with RP. Thirty-five patients with RP and 15 normal subjects were tested. Direct steady-state pupillometric measures were obtained from one eye in a full-field dome after 45 min of dark adaptation by videotaping the pupil with an infrared camera. Mean pupil diameter in the dark was comparable (t = -0.15, P = 0.88) between patients with RP (6.85 +/- 0.58 mm) and normal subjects (6.82 +/- 0.76 mm). The results of the present study are clearly counter to the prediction of the second (weaker) form of the equivalent light hypothesis.


Subject(s)
Dark Adaptation/physiology , Light , Pupil/physiology , Retinitis Pigmentosa/etiology , Adult , Case-Control Studies , Humans , Middle Aged , Retina/anatomy & histology , Retina/physiology , Rod Cell Outer Segment/physiology
8.
Invest Ophthalmol Vis Sci ; 42(8): 1685-90, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11431429

ABSTRACT

PURPOSE: To examine the ocular phenotype in mice heterozygous for a null mutation in the abcr gene. METHODS: Retinas and retinal pigment epithelia (RPE) were prepared from wild-type, abcr+/-, and abcr-/- mice. Fresh tissues were homogenized and analyzed by normal phase high-performance liquid chromatography (HPLC) for the presence of retinoids and phospholipids. In another study, fixed tissues were sectioned and analyzed by light and electron microscopy. Finally, anesthetized mice were studied by electroretinography (ERG) at different times after exposure to strong light. RESULTS: A2E, the major fluorophore of lipofuscin, and its precursors, A2PE-H(2) and A2PE, were approximately fourfold more abundant in 8-month-old abcr+/- than in the wild-type retina and RPE. The levels of these substances in abcr+/- mice were approximately 40% those in abcr-/- mice. Lipofuscin pigment-granules were also visible in abcr+/- RPE cells by electron microscopy. Accumulation of A2PE-H(2) and A2E in abcr+/- retina and RPE, respectively, was strongly dependent on light exposure. Heterozygous mutants also exhibited delayed recovery of rod sensitivity by ERG. This delay was correlated with elevated levels of all-trans-retinaldehyde (all-trans-RAL) in retina after a photobleach and was not caused by a reduction in quantum-catch due to depletion of 11-cis-retinaldehyde (11-cis-RAL). CONCLUSIONS: Partial loss of the ABCR or rim protein is sufficient to cause a phenotype in mice similar to recessive Stargardt's disease (STGD) and age-related macular degeneration (AMD) in humans. These data are consistent with the suggestion that the STGD carrier-state may predispose to the development of AMD.


Subject(s)
ATP-Binding Cassette Transporters/physiology , Dark Adaptation , Lipofuscin/metabolism , Macular Degeneration/metabolism , Rod Cell Outer Segment/metabolism , ATP-Binding Cassette Transporters/genetics , Animals , Chromatography, High Pressure Liquid , Electroretinography , Macular Degeneration/genetics , Macular Degeneration/pathology , Mice , Mice, Mutant Strains , Phenotype , Pigment Epithelium of Eye/metabolism , Retinoids/metabolism , Rod Cell Outer Segment/ultrastructure
9.
Invest Ophthalmol Vis Sci ; 42(6): 1319-27, 2001 May.
Article in English | MEDLINE | ID: mdl-11328746

ABSTRACT

PURPOSE: To define the phenotypic expression of a deletion in the gene encoding the transcription factor CRX in a large, seven-generation, white family. METHODS: Fourteen affected individuals, all heterozygous for the Leu146del12 mutation in the cone-rod homeobox gene (CRX), and four nonaffected relatives from the same family were examined with visual function tests, and 10 underwent bone mineral density (BMD) measurement. RESULTS: The ability of the mutated CRX protein to transactivate rhodopsin promoter was decreased by approximately 25%, and its ability to react synergistically with neural retinal leucine zipper (NRL) was reduced by more than 30%. The affected members of the family had an autosomal dominant ocular condition most closely resembling Leber congenital amaurosis (LCA) with severe visual impairment at an early age. Depending on age, affected members showed varying degrees of significant visual acuity loss, elevated dark-adaptation thresholds, significantly reduced cone and rod electroretinogram (ERG) amplitudes, and progressive constriction of the visual fields, in most cases leading to complete blindness. Six affected members had reduced levels of BMD in the spine and the hip (osteopenia). Four affected female members who were receiving long-term hormonal replacement therapy (HRT) demonstrated normal values of BMD. CONCLUSIONS: This large deletion of the CRX gene is associated with a severe form of autosomal dominant retinal degeneration. Affected members not receiving HRT showed reduced BMD (osteopenia). This phenotype may reflect the abnormal influence of mutant CRX on both retinal and pineal development.


Subject(s)
Base Sequence , Bone Diseases, Metabolic/genetics , Homeodomain Proteins/genetics , Retinal Degeneration/genetics , Sequence Deletion , Trans-Activators/genetics , Adult , Aged , Bone Density , Bone Diseases, Metabolic/drug therapy , Bone Diseases, Metabolic/pathology , Child , Child, Preschool , DNA Mutational Analysis , Electroretinography , Estrogen Replacement Therapy , Female , Genes, Dominant , Humans , Male , Middle Aged , Mutation , Pedigree , Phenotype , Retinal Degeneration/pathology , Vision Disorders/genetics , Visual Acuity
10.
Hum Mutat ; 17(1): 42-51, 2001.
Article in English | MEDLINE | ID: mdl-11139241

ABSTRACT

Inherited retinopathies are a genetically and phenotypically heterogeneous group of diseases affecting approximately one in 2000 individuals worldwide. For the past 10 years, the Laboratory for Molecular Diagnosis of Inherited Eye Diseases (LMDIED) at the University of Texas-Houston Health Science Center has screened subjects ascertained in the United States and Canada for mutations in genes causing dominant and recessive autosomal retinopathies. A combination of single strand conformational analysis (SSCA) and direct sequencing of five genes (rhodopsin, peripherin/RDS, RP1, CRX, and AIPL1) identified the disease-causing mutation in approximately one-third of subjects with autosomal dominant retinitis pigmentosa (adRP) or with autosomal dominant cone-rod dystrophy (adCORD). In addition, the causative mutation was identified in 15% of subjects with Leber congenital amaurosis (LCA). Overall, we report identification of the causative mutation in 105 of 506 (21%) of unrelated subjects (probands) tested; we report five previously unreported mutations in rhodopsin, two in peripherin/RDS, and one previously unreported mutation in the cone-rod homeobox gene, CRX. Based on this large survey, the prevalence of disease-causing mutations in each of these genes within specific disease categories is estimated. These data are useful in estimating the frequency of specific mutations and in selecting individuals and families for mutation-specific studies.


Subject(s)
Membrane Glycoproteins , Mutation , Retinitis Pigmentosa/epidemiology , Retinitis Pigmentosa/genetics , Amino Acid Substitution/genetics , Animals , Arginine/genetics , Cysteine/genetics , Genetic Variation , Glutamine/genetics , Homeodomain Proteins/genetics , Humans , Intermediate Filament Proteins/genetics , Leucine/genetics , Nerve Tissue Proteins/genetics , Optic Atrophies, Hereditary/genetics , Peripherins , Prevalence , Proline/genetics , Retinal Degeneration/genetics , Retinal Diseases/epidemiology , Retinal Diseases/genetics , Rhodopsin/genetics , Trans-Activators/genetics , Tyrosine/genetics
11.
Exp Eye Res ; 73(6): 877-86, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11846518

ABSTRACT

Mutations in the ABCA4(ABCR) gene cause autosomal recessive Stargardt disease (STGD). ABCR mutations were identified in patients with cone-rod dystrophy (CRD) and retinitis pigmentosa (RP) by direct sequencing of all 50 exons in 40 patients. Of 10 patients with RP, one contained two ABCR mutations suggesting a compound heterozygote. This patient had a characteristic fundus appearance with attenuated vessels, pale disks and bone-spicule pigmentation. Rod electroretinograms (ERGs) were non-detectable, cone ERGs were greatly reduced in amplitude and delayed in implicit time, and visual fields were constricted to 10 degrees diameter. Eleven of 30 (37%) patients with CRD had mutations in ABCR. In general, these patients showed reduced but detectable rod ERG responses, reduced and delayed cone responses, and poor visual acuity. Rod photoresponses to high intensity flashes were of reduced maximum amplitude but showed normal values for the gain of phototransduction. Most CRD patients with mutations in ABCR showed delayed recovery of sensitivity (dark adaptation) following exposure to bright light. Pupils were also significantly smaller in these patients compared to controls at 30 min following light exposure, consistent with a persistent 'equivalent light' background due to the accumulation of a tentatively identified 'noisy' photoproduct.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Mutation/genetics , Retinal Degeneration/genetics , Visual Acuity/physiology , Adolescent , Adult , Aged , Child , Dark Adaptation/physiology , Electroretinography , Humans , Middle Aged , Pupil/physiology , Retinal Degeneration/pathology , Vision, Ocular/physiology , Visual Fields/physiology
12.
Doc Ophthalmol ; 101(1): 1-9, 2000 Jul.
Article in English | MEDLINE | ID: mdl-11128963

ABSTRACT

The standard for dark adaptation has long been the Goldmann-Weekers Dark Adaptometer(Haag-Streit). More recently, portable, relatively inexpensive LED-based dark adaptometers have become commercially available. These devices have potential use in areas with limited resources to screen for night-blindness, commonly caused worldwide by vitamin A deficiency. In order to determine the sensitivity to detecting changes in night vision, this study compared one such device, LKC Technologies Scotopic Sensitivity Tester-1 (SST-1) to the Goldmann-Weekers in patients with hereditary retinal degeneration and loss of rod function. Dark-adapted final thresholds and rod full-field ERG responses were obtained from 87 patients and 24 normal subjects. Linear regression analysis, discrepancy analysis, and receiver operator characteristic curves for both devices show that the SST-1 quantifies psychophysical rod function nearly as well as the Goldmann-Weekers, within some limitations. We conclude, therefore, that the SST-1 is a viable alternative to the Goldmann-Weekers for the screening of night-blinding retinal disorders.


Subject(s)
Dark Adaptation , Electrophysiology/instrumentation , Night Blindness/diagnosis , Retinal Degeneration/diagnosis , Retinal Rod Photoreceptor Cells/pathology , Vision Tests/instrumentation , Adolescent , Adult , Aged , Child , Electroretinography , Humans , Middle Aged , Retinal Degeneration/genetics , Sensitivity and Specificity , Sensory Thresholds , Visual Acuity
13.
Nat Genet ; 26(3): 319-23, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11062471

ABSTRACT

During development, visual photoreceptors, bipolar cells and other neurons establish connections within the retina enabling the eye to process visual images over approximately 7 log units of illumination. Within the retina, cells that respond to light increment and light decrement are separated into ON- and OFF-pathways. Hereditary diseases are known to disturb these retinal pathways, causing either progressive degeneration or stationary deficits. Congenital stationary night blindness (CSNB) is a group of stable retinal disorders that are characterized by abnormal night vision. Genetic subtypes of CSNB have been defined and different disease actions have been postulated. The molecular bases have been elucidated in several subtypes, providing a better understanding of the disease mechanisms and developmental retinal neurobiology. Here we have studied 22 families with 'complete' X-linked CSNB (CSNB1; MIM 310500; ref. 4) in which affected males have night blindness, some photopic vision loss and a defect of the ON-pathway. We have found 14 different mutations, including 1 founder mutation in 7 families from the United States, in a novel candidate gene, NYX. NYX, which encodes a glycosylphosphatidyl (GPI)-anchored protein called nyctalopin, is a new and unique member of the small leucine-rich proteoglycan (SLRP) family. The role of other SLRP proteins suggests that mutant nyctalopin disrupts developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB.


Subject(s)
Eye Proteins/genetics , Genes , Interneurons/pathology , Night Blindness/genetics , Proteoglycans/genetics , X Chromosome/genetics , Adult , Amino Acid Motifs , Amino Acid Sequence , DNA Mutational Analysis , DNA, Complementary/genetics , Expressed Sequence Tags , Eye Proteins/chemistry , Eye Proteins/physiology , Gene Expression Profiling , Glycosylphosphatidylinositols/metabolism , Humans , Interneurons/metabolism , Kidney/metabolism , Leucine/analysis , Male , Molecular Sequence Data , Night Blindness/classification , Organ Specificity , Pedigree , Proteoglycans/chemistry , Proteoglycans/deficiency , Proteoglycans/physiology , Repetitive Sequences, Amino Acid , Retina/pathology , Retinal Ganglion Cells/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Synaptic Transmission/physiology , Vision, Ocular/physiology
14.
Ophthalmology ; 107(10): 1950-4, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11013205

ABSTRACT

PURPOSE: To determine the effect of stimulus size on sensitivity of patients with retinitis pigmentosa (RP) as measured by automated static perimetry. DESIGN: Comparative case series. PARTICIPANTS: Thirty-nine patients with RP and a control group of 10 healthy volunteers. METHODS: Automated static perimetry (full threshold programs 24-2 or 30-2) was performed twice on one eye of each participant using stimulus sizes III (0.43 degrees diameter) and V (1.72 degrees diameter). Data from the same 50 test locations were used from each field. MAIN OUTCOME MEASURES: At each location, for each participant, the size effect was computed as the difference (in decibels) in sensitivities for sizes V and III, and the average sensitivity was computed as the mean of sensitivities for the two sizes. RESULTS: For both patient and control groups, the size effect was negatively correlated with average sensitivity (r(2) > 0.124; P: < 0.001). The mean size effect was significantly greater for the patient group than for the control group: 8.6 (+/- 3.6) dB versus 5. 4 (+/- 2.2) dB (t = 18.0; P: < 0.001). The percentage of abnormal locations (more than 8 dB below mean normal) tended to be lower for size V than for size III, with a mean of 67% for size V versus 95% for size III. The percentage of absolute defects was also lower for size V than for size III, with a mean of 35% for size V versus 54% for size III. CONCLUSIONS: In damaged regions of the visual fields of patients with RP, increase in stimulus size from III to V can produce abnormally large increases in perimetric sensitivity. Size III may be more useful than size V for detection of field abnormality, whereas size V may be more useful than size III for observing progression of advanced RP.


Subject(s)
Retina/physiopathology , Retinitis Pigmentosa/physiopathology , Visual Field Tests/methods , Visual Fields/physiology , Humans , Retinitis Pigmentosa/genetics , Sensitivity and Specificity
15.
Ophthalmic Genet ; 21(2): 89-99, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10916183

ABSTRACT

Our aim was to describe the visual function characteristics of affected members from two unrelated families with different dominant mutations in the CRX gene. Standard full-field ERGs and high-intensity a-wave series were obtained. In addition, in most subjects, dark-adapted (DA) thresholds, color vision function (arrangement tests), and static perimetry were assessed. A point mutation in codon 41 of the CRX gene (Arg41Gln) was identified in family members from the RFS087 family who were tested on several occasions since 1983. Depending on age, affected members showed varying degrees of acuity loss, normal or slightly elevated DA thresholds, reduced cone a- and b-wave amplitudes, normal or minimally delayed cone b-wave implicit times, and normal rod and cone phototransduction gain parameters. An insertion mutation (Ala196+1bp) was found in two members of another family (RFS014). Affected members showed reduced visual acuity, normal or slightly elevated DA thresholds, relatively preserved rod ERG and substantially reduced or undetectable cone ERG, and normal rod phototransduction gain parameters. The Arg41Gln was associated with a late-onset, slowly progressing mild form of cone-rod dystrophy with cone loss but preserved rod and cone sensitivity until later in life. The Ala196+1bp mutation was associated with an early-onset, severe form of cone-rod dystrophy similar to that described in the original CORD2 family (Evans et al., Arch Ophthalmol 1995;113:195-201).


Subject(s)
Homeodomain Proteins/genetics , Mutagenesis, Insertional , Photoreceptor Cells, Vertebrate/physiology , Point Mutation , Retinitis Pigmentosa/genetics , Trans-Activators/genetics , Adult , Aged , Child, Preschool , DNA Mutational Analysis , Electroretinography , Female , Genotype , Humans , Male , Middle Aged , Pedigree , Phenotype , Retinitis Pigmentosa/physiopathology , Visual Acuity
16.
Mol Genet Metab ; 70(2): 142-50, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10873396

ABSTRACT

Leber congenital amaurosis (LCA) is the most severe form of inherited retinal dystrophy and the most frequent cause of inherited blindness in children. LCA is usually inherited in an autosomal recessive fashion, although rare dominant cases have been reported. One form of LCA, LCA4, maps to chromosome 17p13 and is genetically distinct from other forms of LCA. We recently identified the gene associated with LCA4, AIPL1 (aryl-hydrocarbon interacting protein-like 1) and identified three mutations that were the cause of blindness in five families with LCA. In this study, AIPL1 was screened for mutations in 512 unrelated probands with a range of retinal degenerative diseases to determine if AIPL1 mutations cause other forms of inherited retinal degeneration and to determine the relative contribution of AIPL1 mutations to inherited retinal disorders in populations worldwide. We identified 11 LCA families whose retinal disorder is caused by homozygous or compound heterozygous AIPL1 mutations. We also identified affected individuals in two apparently dominant families, diagnosed with juvenile retinitis pigmentosa or dominant cone-rod dystrophy, respectively, who are heterozygous for a 12-bp AIPL1 deletion. Our results suggest that AIPL1 mutations cause approximately 7% of LCA worldwide and may cause dominant retinopathy.


Subject(s)
Carrier Proteins/genetics , Mutation , Retinal Degeneration/genetics , Adaptor Proteins, Signal Transducing , Blindness/genetics , Blindness/pathology , DNA Mutational Analysis , DNA Primers/chemistry , Exons , Eye Proteins , Female , Humans , Introns , Male , Optic Atrophies, Hereditary/genetics , Optic Atrophies, Hereditary/pathology , Pedigree , Phenotype , Photoreceptor Cells, Vertebrate/pathology , Polymorphism, Single-Stranded Conformational , Prevalence , Retinal Degeneration/pathology , Sequence Analysis, DNA
18.
Nat Genet ; 25(1): 67-73, 2000 May.
Article in English | MEDLINE | ID: mdl-10802659

ABSTRACT

The homologous membrane proteins Rom-1 and peripherin-2 are localized to the disk rims of photoreceptor outer segments (OSs), where they associate as tetramers and larger oligomers. Disk rims are thought to be critical for disk morphogenesis, OS renewal and the maintenance of OS structure, but the molecules which regulate these processes are unknown. Although peripherin-2 is known to be required for OS formation (because Prph2-/- mice do not form OSs; ref. 6), and mutations in RDS (the human homologue of Prph2) cause retinal degeneration, the relationship of Rom-1 to these processes is uncertain. Here we show that Rom1-/- mice form OSs in which peripherin-2 homotetramers are localized to the disk rims, indicating that peripherin-2 alone is sufficient for both disk and OS morphogenesis. The disks produced in Rom1-/- mice were large, rod OSs were highly disorganized (a phenotype which largely normalized with age) and rod photoreceptors died slowly by apoptosis. Furthermore, the maximal photoresponse of Rom1-/- rod photoreceptors was lower than that of controls. We conclude that Rom-1 is required for the regulation of disk morphogenesis and the viability of mammalian rod photoreceptors, and that mutations in human ROM1 may cause recessive photoreceptor degeneration.


Subject(s)
Eye Proteins/physiology , Membrane Glycoproteins , Membrane Proteins/physiology , Optic Disk/growth & development , Retinal Rod Photoreceptor Cells/physiology , Animals , Electroretinography , Eye Proteins/genetics , Eye Proteins/metabolism , Female , Humans , Intermediate Filament Proteins/metabolism , Kinetics , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred BALB C , Mice, Knockout , Morphogenesis/genetics , Nerve Tissue Proteins/metabolism , Optic Disk/ultrastructure , Peripherins , Retinal Degeneration/genetics , Retinal Degeneration/metabolism , Retinal Rod Photoreceptor Cells/ultrastructure , Rod Cell Outer Segment/growth & development , Rod Cell Outer Segment/ultrastructure , Tetraspanins
19.
Mol Vis ; 6: 6-9, 2000 Feb 22.
Article in English | MEDLINE | ID: mdl-10706894

ABSTRACT

PURPOSE: To determine the genomic organization of diacylglycerol kinase(iota) and to test whether defects in this gene are present in individuals affected with autosomal dominant retinitis pigmentosa (adRP). Diacylglycerol kinase(iota) has been mapped to the RP10 locus on 7q and shows 49% sequence similarity to the Drosophila DGK2 rdgA gene. Since mutations in the DGK2 rdgA gene cause photoreceptor degeneration in Drosophila, it is possible that mutations in diacylglycerol kinase(iota) could be responsible for human retinal degeneration. METHODS: DNA sequence from genomic clones containing diacylglycerol kinase(iota) was compared with the cDNA sequence to identify intron/exon boundaries. Single-strand conformational analysis and PCR product sequencing were used to screen members of one family previously mapped to the RP10 locus and 47 small unmapped families with autosomal dominant retinitis pigmentosa. RESULTS: Diacylglycerol kinase(iota) is divided into 35 exons with the initiation codon being present in exon 2. Mutational analysis found a missense change (Lys153Phe) in three adRP families; however, it did not segregate with disease in one of the families. Silent substitutions were seen in codons 865 and 875. Intronic variation was detected in the amplifications of exons 3,5,18, 28, and 32; these do not affect splice site consensus sequences. Typing of a polymorphic variant detected in intron 31 in members of the RP10 family gave a LOD score of -4.2 at 0% recombination. CONCLUSIONS: No evidence of disease-associated mutations was found in any of the samples tested. Based on the linkage data and mutation screening, diacylglycerol kinase(iota) is excluded as a candidate for the RP10 form of adRP and cannot be a frequent cause of other forms of adRP. Mutations in diacylglycerol kinase(iota) may yet be the cause of recessive forms of retinal degeneration in humans, either in homozygous or compound heterozygous forms. The data provided here will permit testing of this hypothesis.


Subject(s)
Chromosomes, Human, Pair 7 , Diacylglycerol Kinase/genetics , Retinitis Pigmentosa/genetics , Adult , Animals , Chromosome Mapping , DNA Mutational Analysis , Drosophila/enzymology , Drosophila/genetics , Exons , Female , Humans , Introns , Male , Molecular Sequence Data , Polymorphism, Genetic , Retinitis Pigmentosa/enzymology
20.
J Pediatr Gastroenterol Nutr ; 31(5): 540-53, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11144440

ABSTRACT

BACKGROUND: In contrast to human milk, current infant formulas in the United States do not contain omega3 and omega6 long-chain polyunsaturated fatty acids. This may lead to suboptimal blood lipid fatty acid profiles and to a measurable diminution of visual function in developing term infants. The need for docosahexaenoic acid and arachidonic acid supplementation in the infant diet was evaluated in a double-blind, randomized clinical trial. METHODS: Healthy term infants were randomized to diets of (1) commercial formula, (2) docosahexaenoic acid-enriched formula (0.35% of total fatty acids), or (3) docosahexaenoic acid- (0.36%) and arachidonic acid- (0.72%) enriched formula. Eighty-seven infants completed the 17-week nutritional trial, and 58 were observed until 52 weeks of life. A reference group was exclusively breast fed for at least 17 weeks (n = 29). Outcome measures included electroretinographic responses, visual evoked potentials, and blood fatty acid analysis in infants at birth and at 6, 17, and 52 weeks of age. RESULTS: Commercial formula-fed infants had 30% to 50% lower content of docosahexaenoic acid in total red blood cell lipids during the 17-week feeding trial compared with breastfed infants. Significant differences persisted at the 1-year follow-up. Arachidonic acid content was consistently reduced in the commercial formula group by 15% to 20%. Infants fed long-chain polyunsaturated fatty acid-enriched formulas had docosahexaenoic acid and arachidonic acid blood lipid profiles resembling those of human milk-fed infants. Infants receiving this enriched formula had more mature electroretinographic responses than commercial formula-fed infants at 6 weeks of age. Human milk-fed and docosahexaenoic acid-enriched formula-fed infants had better visual acuity than commercial formula-fed infants at both 17 and 52 weeks of age. Early (17-week) fatty acid profiles in blood lipids were correlated with later (52-week) visual function development in study infants. CONCLUSIONS: Results from this clinical trial demonstrate that long-chain polyunsaturated fatty acid supplementation of formula in term infants produces blood lipid fatty acid profiles that are similar to those observed in breast-fed infants. This supplementation leads to better visual function later in life (i.e., 1 year of age) than that shown by infants fed commercial formula.


Subject(s)
Arachidonic Acid/pharmacology , Docosahexaenoic Acids/pharmacology , Evoked Potentials, Visual/drug effects , Fatty Acids/blood , Infant Food , Visual Acuity/drug effects , Arachidonic Acid/administration & dosage , Arachidonic Acid/blood , Bottle Feeding , Breast Feeding , Cohort Studies , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/blood , Double-Blind Method , Electroretinography , Erythrocytes/chemistry , Evoked Potentials, Visual/physiology , Fatty Acids/analysis , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/analysis , Fatty Acids, Omega-6 , Fatty Acids, Unsaturated/administration & dosage , Fatty Acids, Unsaturated/analysis , Female , Fetal Blood/chemistry , Humans , Infant , Infant Food/analysis , Infant Nutritional Physiological Phenomena , Infant, Newborn , Lipids/blood , Lipids/chemistry , Retina/drug effects , Retina/physiology , Visual Acuity/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...